Previous 10 | Next 10 |
BioLife Solutions is a leading company focused on the cell therapy market. The company has demonstrated strong growth and market adoption even through COVID. The company has a differentiated technology platform that will allow them to take share over time. Valuation is healthy...
WORCESTER, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- iVexSol , a rapidly growing lentiviral vector (LVV) manufacturing company, today announced the closure of a $13.0M Series A funding round. A total of $15.2M has been raised to date from current investors Casdin Capital, LLC , a...
BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools Follow-...
BioLife Solutions Ranked 403rd Fastest Growing Company in North America on Deloitte's 2020 Technology Fast 500™ PR Newswire BOTHELL, Wash., Nov. 19, 2020 BOTHELL, Wash. , Nov. 19, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ...
BioLife Solutions, Inc. (BLFS) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Rod de Greef - Chief Financial Officer Michael Rice - Chief Executive Officer Conference Call Participants Chris Lin - Cowen and Company Mason Carrico - Stephens Inc. Thomas Flaten...
Image source: The Motley Fool. Biolife Solutions Inc (NASDAQ: BLFS) Q3 2020 Earnings Call Nov 5, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Biolife Solutions Inc (BLFS) Q3 2020 Earnings Call Transcript
BioLife Solutions (BLFS): Q3 Non-GAAP EPS of -$0.02 in-line; GAAP EPS of -$0.04 misses by $0.02.Revenue of $11.3M (+71.2% Y/Y) beats by $0.52M.Due to uncertainty regarding the impact of the COVID-19 pandemic on BioLife and its customers, the Company withdrew its financial guidance for 2020.Sh...
BioLife Solutions Announces Third Quarter 2020 Financial Results Q3 total revenue of $11.3 million increased 71% over the prior year Three month media revenue up 22% versus 2019 Conference call begins at 4:30 p.m. Eastern time today PR Newswire BOTHELL, Wash., No...
BioLife Solutions to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020 PR Newswire BOTHELL, Wash., Oct. 29, 2020 BOTHELL, Wash. , Oct. 29, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) (...
BioLife Solutions' (BLFS) SciSafe division has been awarded a two year contract, worth ~$2.7M, from a large pharmaceutical company for cold chain management and storage of COVID-19 vaccines.Management estimates that SciSafe will contribute ~ $9M in incremental revenue in 2021.Quick look at hi...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...